0001630384-21-000002.txt : 20210803
0001630384-21-000002.hdr.sgml : 20210803
20210803112653
ACCESSION NUMBER: 0001630384-21-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210803
DATE AS OF CHANGE: 20210803
EFFECTIVENESS DATE: 20210803
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CirrusMD Inc.
CENTRAL INDEX KEY: 0001630384
IRS NUMBER: 454969037
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-408573
FILM NUMBER: 211138520
BUSINESS ADDRESS:
STREET 1: 3513 BRIGHTON BOULEVARD, SUITE 230
CITY: DENVER
STATE: CO
ZIP: 80216
BUSINESS PHONE: 800-449-4512
MAIL ADDRESS:
STREET 1: 3513 BRIGHTON BOULEVARD, SUITE 230
CITY: DENVER
STATE: CO
ZIP: 80216
D
1
primary_doc.xml
X0708
D
LIVE
0001630384
CirrusMD Inc.
3513 BRIGHTON BOULEVARD, SUITE 230
DENVER
CO
COLORADO
80216
800-449-4512
DELAWARE
None
None
Corporation
true
ANDREW
ALTORFER
c/o CirrusMD Inc. 3513 Brighton Blvd.
Suite 230
DENVER
CO
COLORADO
80216
Executive Officer
Director
Promoter
RYAN
KIRKPATRICK
c/o CirrusMD Inc. 3513 Brighton Blvd.
Suite 230
DENVER
CO
COLORADO
80216
Director
GABE
VARELA
c/o CirrusMD Inc. 3513 Brighton Blvd.
Suite 230
DENVER
CO
COLORADO
80216
Executive Officer
JEFF
COOK
c/o CirrusMD Inc. 3513 Brighton Blvd.
Suite 230
DENVER
CO
COLORADO
80216
Director
MOLLY
BONAKDARPOUR
c/o CirrusMD Inc. 3513 Brighton Blvd.
Suite 230
DENVER
CO
COLORADO
80216
Director
JOHN
JEPSEN
c/o CirrusMD Inc. 3513 Brighton Blvd.
Suite 230
DENVER
CO
COLORADO
80216
Executive Officer
Promoter
WALLACE
BLAKE
MCKINNEY
c/o CirrusMD Inc. 3513 Brighton Blvd.
Suite 230
DENVER
CO
COLORADO
80216
Executive Officer
JAMES
C.T.
LINFIELD
c/o CirrusMD Inc. 3513 Brighton Blvd.
Suite 230
DENVER
CO
COLORADO
80216
Executive Officer
KELSEY
MAGUIRE
c/o CirrusMD Inc. 3513 Brighton Blvd.
Suite 230
DENVER
CO
COLORADO
80216
Director
Other Health Care
Decline to Disclose
- 06b
false
2021-06-29
false
true
true
false
0
126132
126132
0
false
1
0
0
0
false
CirrusMD Inc.
/s/ Andrew Altorfer
Andrew Altorfer
Chief Executive Officer
2021-08-03